CD4 and acute myeloid leukemia: RBC alloimmunization leads to CD4+ TL differentiation, resulting in a Th17 profile in 56% of alloimmunized patients, whereas treated AML patients had lower frequencies of Th17 cells (7, 9, 25, 26).